Teva’s third strike at the Japanese generic market, the new favorite of drug makers
Last fortnight,
Japan dominated the pharmaceutical deal making scenario, giving us the much
needed
How little-known Lannett may soon become a billion-dollar generic company?
In August, when Fortune magazine
published its latest ranking of the fastest-growing companies in t
Plan an African safari to discover the world’s fastest growing pharmaceutical opportunity
Africa represents the last geographic frontier where high growth is still achievable. Over the past
With a $1.2 billion buy, Concordia re-affirms that old drugs are indeed gold!
Canada based, Concordia Healthcare continued their buying spree of old, established drug brands